Thoroughbred Financial Services, LLC Crispr Therapeutics Ag Transaction History

Thoroughbred Financial Services, LLC

  • $1.55 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022
SELL
$70.09 - $111.29 $144,735 - $229,813
-2,065 Closed
0 $0
Q3 2021

Oct 27, 2021
SELL
$110.2 - $156.64 $21,599 - $30,701
-196 Reduced 8.67%
2,065 $231,000
Q2 2021

Jul 27, 2021
BUY
$100.84 - $161.89 $7,563 - $12,141
75 Added 3.43%
2,261 $366,000
Q1 2021

Apr 30, 2021
BUY
$110.72 - $210.04 $242,033 - $459,147
2,186 New
2,186 $266,000

Others Institutions Holding CRSP

# of Institutions
490
Shares Held
58M
Call Options Held
1.1M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.18B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email